Premium
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI 2 )
Author(s) -
DOWD PAULINE M.,
MARTIN M.F.R.,
COOKE E.D.,
BOWCOCK SALLY A.,
JONES R.,
DIEPPE P.A.,
KIRBY J.D.T.
Publication year - 1982
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1982.tb00905.x
Subject(s) - prostacyclin , raynaud disease , iloprost , medicine , scleroderma (fungus) , pathology , inoculation
SUMMARY Twenty five patients with Raynaud's phenomenon due to systemic sclerosis were infused with prostacyclin (PGI 2 ). In 88% of the patients there was objective improvement, monitored by thermography or radiometry.